top of page
Search

Immune organoids expedite conjugate vaccine testing

  • Writer: DLRG
    DLRG
  • Apr 12, 2023
  • 1 min read

Updated: Jun 2, 2024

Recent collaborative work by the DeLisa and Singh groups describes a new immune organic platform for rapid, high-throughput testing of glycoconjugate vaccine candidates


Ty Moeller of the DeLisa group together with Shiv Shaw of the Singh group (Georgia Tech) have joined forces to create a synthetic immune organoid system that can quickly predict how well conjugate vaccines will work and speed up the process of finding antigen-specific antibodies. By sidestepping animal immunization, this immune organoid-based approach enabled antibody discovery on a time scale that was significantly shorter than for conventional immunization-based workflows. The article, “Profiling Germinal Center-like B Cell Responses to Conjugate Vaccines Using Synthetic Immune Organoids,” was published in ACS Central Science.


To read the full story by Genetic Engineering and Biotechnology News, go here:



 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.

Robert F. Smith School of Chemical and Biomolecular Engineering, Cornell University

  • Facebook Clean Grey
  • Twitter Clean Grey
  • LinkedIn Clean Grey

© 2018 by DLRG. Proudly created with Wix.com

bottom of page